A Rare Disease With Diverse Manifestations
暂无分享,去创建一个
[1] A. Hofman,et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[2] H. Segev,et al. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family , 1995, Human Genetics.
[3] Y. Tokimura,et al. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use , 1994, Journal of the Neurological Sciences.
[4] A. Federico,et al. Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism , 1993, Journal of the Neurological Sciences.
[5] U. Francke,et al. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. , 1991, The Journal of biological chemistry.
[6] G. Ness,et al. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis. , 1990, The Journal of clinical investigation.
[7] N. Le,et al. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis. , 1989, Journal of lipid research.
[8] A. Quyyumi,et al. Aneurysmal coronary artery disease in cerebrotendinous xanthomatosis. , 1988, The American journal of cardiology.
[9] B. G. Wolthers,et al. Cerebrotendinous xanthomatosis: A review of biochemical findings of the patient population in the netherlands , 1988, Journal of Inherited Metabolic Disease.
[10] G. Tint,et al. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. , 1987, The New England journal of medicine.
[11] S. Shefer,et al. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.
[12] G. Tint,et al. Transformation of 4-cholesten-3-one and 7α-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis , 1984 .
[13] S. Grundy,et al. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. , 1973, The Journal of clinical investigation.
[14] G. Salen. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. , 1971, Annals of internal medicine.